FCX-DNA New DNA Specific Cosmetic Line Targets the Unique 1% of DNA.

. FCX Cosmetic Company to Launch October 1st in Eagle, Idaho.

Boise, ID, September 15, 2011 --(PR.com)-- A revolutionary FDA-approved DNA personalized cosmetic line is being brought to the public by Full Circle Rewards Inc and referred to as FCX-DNA and the spokesperson for the company Dr. Tamara Simon, MD will help to educate the public about this Revolutionary Product. These DNA products offer potent nutrient blends of vitamins, minerals and other natural extracts to delay skin aging, protect skin from DNA damage caused by UV radiation and environmental pollutants, prevent premature skin aging, stimulate skin cell regeneration, and provide optimal skin nourishing and moisturizing. FCX designed DNA testing called Anti-Aging DNA to detect gene mutations affecting skin aging, nutrient metabolism, and susceptibility to disease which affects both the appearance of skin and general health status. FCX learns about each person's genetic profile and can recommend appropriate preventive measures to delay the onset of aging and the formation of wrinkles. Genes tested are related to dermagenomics, collagen synthesis, skin anti-oxidation and replenishment, early hair loss, and skin cancers such as basal cell carcinoma and melanoma. FCX's skin and body care is a regiment consisting of shampoo, conditioner, soaps and cleansers, as well as products for detoxifying, cell renewal and anti-aging. The science behind these remarkable new products, developed by Burstein Ecological Laboratories - a leading research laboratory in natural cosmetics - is Bio Anti-Aging Technology. This progressive technology is the micronized process of ingredients, breaking them down to their smallest living particle for ultimate delivery allowing for the best results in skin care, hair care, and nutrition. The research, founded by Dr. M. Burstein, one of the most state-of-the-art laboratories in the world, is equipped with cutting-edge scientific equipment used to research and produce natural cosmetics. After years of study, research and data collection, Dr. Burstein developed a process to extract the essence from organically grown fruits and vegetables without harming its texture or genetics. Dr. Tamara Simon, MD., MPH, FACOG, who serves as FCX's Medical Director, and educates the public on the medical and molecular science of these DNA products. Dr Tamara Simon, MD., is also building and developing a longevity center focused on healthy living and age management. Dr. Mario S. Kambouris, Ph.D., FACMG, a professor at Yale University of Medicine in the department of Genetics, serves as the FCX scientist for DNA products as well as the Molecular and Medical Genetics Director. Creating the vision of FCX, local publisher and FCX President, Tia Markland-Crabtree partnered with FCX CEO Sandra Harshman. Ms. Markland-Crabtree brings over 10 years of strategic marketing and
Page 1/3 PR.com Press Release Distribution

Terms of Use

publishing as well as international success as a top distributor with a health and wellness company. Ms. Harshman, one of the first female accountants in Idaho has worked as a tax accountant and comptroller for companies such as Touche Ross & Company and Pepsi Cola Corporation and also was a MSP for over 17 years providing merchant servics an card issuance. Ms. Harshman is the recipient of the National Business Women of the Year Award in 2003 as well as a publisher and author. FCX's astounding DNA products are available beginning October 2011 on the FCX website; FCX-DNA.com. And will be marketed on a worldwide basis through a Multi Level Marketing Chanell. More information can also be found at FCX-DNA.com, or contact the corporate office. Corporate Office 1701 N. Regal Drive Boise, Idaho 83704 1-208-376-1446 1-855-552-9362 ###

Page 2/3 PR.com Press Release Distribution

Terms of Use

Contact Information: Full Circle Rewards Inc. Sandra Harshman 208-322-6602 Contact via Email www.fcx-dna.com

Online Version of Press Release: You can read the online version of this press release at: http://www.pr.com/press-release/353446

News Image:

Page 3/3 PR.com Press Release Distribution

Terms of Use